Comment
Author: Admin | 2025-04-28
Are presented as a scatter dot plot with the median indicated. A Mann–Whitney-U test was performed to test for significance. Figure 2. Local sGPVI and CXCL4 concentrations distal to cerebral artery occlusion in hyper-acute stroke. Local systemic (depicted by black points) and ischemic (depicted by grey points) plasma levels of sGPVI and CXCL4 in patients with either ≥50% cervical ICA stenosis or ICA dissection (A,C) and patients without significant ICA pathology (B,D). The data are presented as a scatter dot plot with the median indicated. A Wilcoxon rank-sum test was performed to test for significance. * p-value p-value Figure 2. Local sGPVI and CXCL4 concentrations distal to cerebral artery occlusion in hyper-acute stroke. Local systemic (depicted by black points) and ischemic (depicted by grey points) plasma levels of sGPVI and CXCL4 in patients with either ≥50% cervical ICA stenosis or ICA dissection (A,C) and patients without significant ICA pathology (B,D). The data are presented as a scatter dot plot with the median indicated. A Wilcoxon rank-sum test was performed to test for significance. * p-value p-value Table 1. Demographic, clinical, and laboratory characteristics of patients (n = 105). Table 1. Demographic, clinical, and laboratory characteristics of patients (n = 105). Subgroup with no Significant ICA PathologyVariable%Mean95% CIMin.–Max.nDemographics Age [years] 76.373.6–79.043–9472 Male sex66.7 48Medical history and medication Atrial fibrillation55.6 40 Antithrombotic medication55.6 40Alteplase treatment38.9 28sGPVI concentration (ng/mL) Systemic 3.22.3–4.20.4–26.972 Ischemic 3.32.4–4.20.6–26.072CXCL4 concentration (ng/mL) Systemic 247.0157.5–336.612.8–1845.063 Ischemic 330.7211.7–449.715.2–1991.063Subgroup with ≥50% ipsilateral symptomatic ICA stenosisDemographics Age [years] 71.767.3–76.049–9033 Male sex66.7 22Medical history and medication Atrial fibrillation27.3 9 Antithrombotic medication27.3 9 Alteplase treatment42.4 14 Stenting/PTA60.6 20 ICA dissection15.2 5sGPVI concentration (ng/mL) Systemic 3.21.5–5.00.7–26.633 Ischemic 3.21.3–5.10.8–25.833CXCL4 concentration (ng/mL) Systemic 215.437.93–392.820.21–2369.028 Ischemic 263.8139.3–388.29.350–1278.028 Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Share and Cite MDPI and ACS Style Starke, A.; Kollikowski, A.M.; Vogt, V.; Stoll, G.; Nieswandt, B.; Pham, M.; Stegner, D.; Schuhmann, M.K. Soluble Glycoprotein VI Levels Assessed Locally within the Extra- and Intracerebral Circulation in Hyper-Acute Thromboembolic Stroke: A Pilot Study. Biomedicines 2024, 12, 2191. https://doi.org/10.3390/biomedicines12102191 AMA Style Starke A, Kollikowski AM, Vogt V, Stoll G, Nieswandt B, Pham M, Stegner D, Schuhmann MK. Soluble Glycoprotein VI Levels Assessed Locally within the Extra- and Intracerebral Circulation in Hyper-Acute Thromboembolic Stroke: A Pilot Study. Biomedicines. 2024; 12(10):2191. https://doi.org/10.3390/biomedicines12102191 Chicago/Turabian Style Starke, Andreas, Alexander M. Kollikowski, Vivian Vogt, Guido Stoll, Bernhard Nieswandt, Mirko Pham, David Stegner, and Michael K. Schuhmann. 2024. "Soluble Glycoprotein VI Levels Assessed Locally within the Extra- and Intracerebral Circulation in Hyper-Acute Thromboembolic Stroke: A Pilot Study" Biomedicines 12, no. 10: 2191. https://doi.org/10.3390/biomedicines12102191 APA Style Starke, A.,
Add Comment